US Tecfidera Sales Could Plunge By $2.8bn In 2021

Market Reacts To Mylan ‘At-Risk’ Launch

 
• By Dean Rudge
  
Dollars_Pills
Tecfidera revenues will greatly diminish if Mylan and other generics flood the market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business